68Ga-PSMA Cerenkov luminescence imaging in primary prostate cancer: first-in-man series

to related objects

Location
Deutsche Nationalbibliothek Frankfurt am Main
ISSN
1619-7089
Extent
Online-Ressource
Language
Englisch
Notes
online resource.

Bibliographic citation
68Ga-PSMA Cerenkov luminescence imaging in primary prostate cancer: first-in-man series ; day:2 ; month:4 ; year:2020 ; pages:1-9
European journal of nuclear medicine and molecular imaging ; (2.4.2020), 1-9

Creator
olde Heuvel, Judith
de Wit-van der Veen, Berlinda J.
van der Poel, Henk G.
Bekers, Elise M.
Grootendorst, Maarten R.
Vyas, Kunal N.
Slump, Cornelis H.
Stokkel, Marcel P. M.
Contributor
SpringerLink (Online service)

DOI
10.1007/s00259-020-04783-1
URN
urn:nbn:de:101:1-2020062113105311736118
Rights
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
Last update
14.08.2025, 10:46 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Show original at data provider

Associated

  • olde Heuvel, Judith
  • de Wit-van der Veen, Berlinda J.
  • van der Poel, Henk G.
  • Bekers, Elise M.
  • Grootendorst, Maarten R.
  • Vyas, Kunal N.
  • Slump, Cornelis H.
  • Stokkel, Marcel P. M.
  • SpringerLink (Online service)

Other Objects (12)

[68Ga]Ga-PSMA-11: The First FDA-Approved 68Ga-Radiopharmaceutical for PET Imaging of Prostate Cancer

[68Ga]Ga-PSMA-11: The First FDA-Approved 68Ga-Radiopharmaceutical for PET Imaging of Prostate Cancer

Recurrent prostate cancer: combined role for MRI and PSMA-PET in 68Ga-PSMA-11 PET/MRI

Recurrent prostate cancer: combined role for MRI and PSMA-PET in 68Ga-PSMA-11 PET/MRI

68Ga-PSMA I&T PET/CT for primary staging of prostate cancer

68Ga-PSMA I&T PET/CT for primary staging of prostate cancer

Radiation dosimetry of [68Ga]PSMA-11 in low-risk prostate cancer patients

Radiation dosimetry of [68Ga]PSMA-11 in low-risk prostate cancer patients

44Sc-PSMA-617 for radiotheragnostics in tandem with 177Lu-PSMA-617—preclinical investigations in comparison with 68Ga-PSMA-11 and 68Ga-PSMA-617

44Sc-PSMA-617 for radiotheragnostics in tandem with 177Lu-PSMA-617—preclinical investigations in comparison with 68Ga-PSMA-11 and 68Ga-PSMA-617

68Ga-PSMA I&T PET/CT for primary staging of prostate cancer [Abstract]

68Ga-PSMA I&T PET/CT for primary staging of prostate cancer [Abstract]

68Ga-PSMA PET/CT in early relapsed prostate cancer patients after radical therapy

68Ga-PSMA PET/CT in early relapsed prostate cancer patients after radical therapy

68Ga-PSMA and 68Ga-FAPI radioligands in the diagnosis of tumors

Hochschulschrift

68Ga-PSMA and 68Ga-FAPI radioligands in the diagnosis of tumors

The Role of 68Ga PSMA Imaging in Evaluating Adrenal Lesions in Prostate Cancer Patients

The Role of 68Ga PSMA Imaging in Evaluating Adrenal Lesions in Prostate Cancer Patients

Cancers and Benign Processes on 68Ga PSMA PET-CT Imaging Other than Prostate Cancer

Cancers and Benign Processes on 68Ga PSMA PET-CT Imaging Other than Prostate Cancer

Metabolic response after 68Ga-PSMA-PET/CT-directed IGRT/SBRT for oligometastases prostate cancer

Metabolic response after 68Ga-PSMA-PET/CT-directed IGRT/SBRT for oligometastases prostate cancer

Systemic therapy response evaluation in prostate carcinoma with [68Ga]Ga-PSMA-11 PET/CT

Systemic therapy response evaluation in prostate carcinoma with [68Ga]Ga-PSMA-11 PET/CT

Related objects